Published in Proc Natl Acad Sci U S A on February 01, 1985
Transcriptional and posttranscriptional control of c-myc during myogenesis: its mRNA remains inducible in differentiated cells and does not suppress the differentiated phenotype. Mol Cell Biol (1986) 4.46
Rapid cytoplasmic turnover of c-myc mRNA: requirement of the 3' untranslated sequences. Mol Cell Biol (1987) 3.99
Poly(A) shortening and degradation of the 3' A+U-rich sequences of human c-myc mRNA in a cell-free system. Mol Cell Biol (1988) 3.96
Transcriptional arrest within the first exon is a fast control mechanism in c-myc gene expression. Nucleic Acids Res (1986) 2.71
Increased rate of degradation of c-myc mRNA in interferon-treated Daudi cells. Proc Natl Acad Sci U S A (1985) 2.35
Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol Cell Biol (1988) 2.20
Cardiac myocyte hypertrophy is associated with c-myc protooncogene expression. Proc Natl Acad Sci U S A (1986) 2.00
The first exon of the c-myc proto-oncogene contains a novel positive control element. EMBO J (1986) 1.80
Aberrant c-myc RNAs of Burkitt's lymphoma cells have longer half-lives. EMBO J (1985) 1.76
Transcriptional and post-transcriptional regulation of c-myc expression during the differentiation of murine erythroleukemia Friend cells. Nucleic Acids Res (1986) 1.62
Cells resistant to interferon are defective in activation of a promoter-binding factor. EMBO J (1988) 1.60
Mitogenic stimulation of thymocytes results in the calcium-dependent phosphorylation of c-ets-1 proteins. EMBO J (1988) 1.58
Two distinct mechanisms of transcriptional control operate on c-myc during differentiation of HL60 cells. Mol Cell Biol (1988) 1.51
Differential stability of c-myc mRNAS in a cell-free system. Mol Cell Biol (1988) 1.37
Transcriptional regulation of interferon-responsive genes is closely linked to interferon receptor occupancy. EMBO J (1986) 1.36
Interferon-induced gene expression in wild-type and interferon-resistant human lymphoblastoid (Daudi) cells. J Virol (1986) 1.31
Post-transcriptional control of the interferon system. Biochimie (2007) 1.28
Interferons and interleukin 6 suppress phosphorylation of the retinoblastoma protein in growth-sensitive hematopoietic cells. Proc Natl Acad Sci U S A (1992) 1.24
Antiproliferative Properties of Type I and Type II Interferon. Pharmaceuticals (Basel) (2010) 1.22
Transcriptional inactivation of c-myc and the transferrin receptor in dibutyryl cyclic AMP-treated HL-60 cells. Mol Cell Biol (1987) 1.20
Identification of sequences in c-myc mRNA that regulate its steady-state levels. Mol Cell Biol (1996) 1.18
A phorbol ester-regulated ribonuclease system controlling transforming growth factor beta 1 gene expression in hematopoietic cells. Mol Cell Biol (1990) 1.17
Downregulation of interleukin 8 gene expression in human fibroblasts: unique mechanism of transcriptional inhibition by interferon. Proc Natl Acad Sci U S A (1992) 1.15
Tumor necrosis factor inhibits MYC expression in HL-60 cells at the level of mRNA transcription. Proc Natl Acad Sci U S A (1987) 1.13
Coding elements in exons 2 and 3 target c-myc mRNA downregulation during myogenic differentiation. Mol Cell Biol (1997) 1.04
Heparin inhibits c-fos and c-myc mRNA expression in vascular smooth muscle cells. Cell Regul (1990) 1.01
Post-transcriptional mechanisms of deregulation of MYC following conversion of a human B cell line by Epstein-Barr virus. EMBO J (1989) 0.99
Recessive genetic deregulation abrogates c-myc suppression by interferon and is implicated in oncogenesis. Mol Cell Biol (1988) 0.99
Inhibitory effects of interferon on the expression of genes regulated by platelet-derived growth factor. Proc Natl Acad Sci U S A (1985) 0.98
1,25-Dihydroxyvitamin D3 modulates the expression of a lymphokine (granulocyte-macrophage colony-stimulating factor) posttranscriptionally. J Clin Invest (1988) 0.94
Alpha-interferon inhibits the expression of heavy chain mu messenger RNA in Daudi cells. EMBO J (1988) 0.93
Germ line c-myc is not down-regulated by loss or exclusion of activating factors in myc-induced macrophage tumors. Mol Cell Biol (1989) 0.93
Alpha 1-adrenergic receptor mRNA level is regulated by norepinephrine in rabbit aortic smooth muscle cells. Proc Natl Acad Sci U S A (1990) 0.92
Interferon modulation of c-myc expression in cloned Daudi cells: relationship to the phenotype of interferon resistance. Mol Cell Biol (1986) 0.90
In vivo generation of 3' and 5' truncated species in the process of c-myc mRNA decay. Nucleic Acids Res (1996) 0.87
Truncation does not abrogate transcriptional downregulation of the c-myc gene by sodium butyrate in Burkitt's lymphoma cells. EMBO J (1987) 0.87
Expression of c-myc proto-oncogene in normal human lymphocytes. Regulation by transcriptional and posttranscriptional mechanisms. J Clin Invest (1987) 0.86
Murine gamma interferon inhibits v-mos-induced fibroblast transformation via down regulation of retroviral gene expression. J Virol (1987) 0.84
Relationship of myc protein expression to the phenotype and to the growth potential of HOC-7 ovarian cancer cells. Br J Cancer (1992) 0.83
Stimulation of pancreatic islet beta-cell replication by oncogenes. Proc Natl Acad Sci U S A (1988) 0.81
Regulation of macrophage growth and antiviral activity by interferon-gamma. J Cell Biol (1989) 0.80
Increased activity of oligo-2',5'-adenylate synthetase in Down's syndrome and epilepsy. Clin Exp Immunol (1987) 0.79
Mechanism of interferon action: alpha and gamma interferons differentially affect mRNA levels of the catalytic subunit of protein kinase A and protein Mx in human cells. J Virol (1992) 0.78
Inhibition of polypeptide chain initiation in Daudi cells by interferons. Evidence that activity of initiation factor eIF-2 and availability of mRNA are unimpaired. Biochem J (1986) 0.77
Chemical synthesis and biological characterization of phosphorothioate analogs of 2', 5'-3'-deoxyadenylate trimer. Nucleic Acids Res (1993) 0.77
Posttranscriptional changes in growth factor-inducible gene regulation caused by antiproliferative interferons. Cell Regul (1990) 0.76
Interferon alfa-2b in the treatment of chronic granulocytic leukemia. Invest New Drugs (1987) 0.75
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc Natl Acad Sci U S A (1972) 83.88
Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature (1983) 19.76
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell (1983) 17.87
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis. Nature (1981) 17.31
Transcriptional regulation of hemoglobin switching in chicken embryos. Mol Cell Biol (1981) 9.97
The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphoma. Cell (1983) 8.54
Surface IgM-kappa specificity on a Burkitt lymphoma cell in vivo and in derived culture lines. Cancer Res (1968) 7.53
Biochemistry of interferons and their actions. Annu Rev Biochem (1982) 6.89
Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell (1984) 6.53
Steps in the processing of Ad2 mRNA: poly(A)+ nuclear sequences are conserved and poly(A) addition precedes splicing. Cell (1978) 6.36
Translocations among antibody genes in human cancer. Science (1983) 6.20
Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature (1982) 5.11
Transcriptional induction of two genes in human cells by beta interferon. Proc Natl Acad Sci U S A (1984) 4.84
Competition hybridization by "pre-saturation" of HeLa cell DNA. J Mol Biol (1969) 3.40
Activation of the c-myc gene by translocation: a model for translational control. Proc Natl Acad Sci U S A (1983) 3.36
Transcripts from the adenovirus-2 major late promoter yield a single early family of 3' coterminal mRNAs and five late families. Cell (1980) 3.21
Regulation of myc gene expression in HL-60 leukaemia cells by a vitamin D metabolite. Nature (1984) 3.06
Quantitative studies on viral interference in suspended L cells. III. Effect of interfering viruses and interferon on the growth rate of cells. Virology (1962) 3.00
Globin RNA transcription: a possible termination site and demonstration of transcriptional control correlated with altered chromatin structure. Cell (1982) 2.72
Growth-dependent expression of dihydrofolate reductase mRNA from modular cDNA genes. Mol Cell Biol (1983) 2.02
Molecular cloning and sequence of partial cDNA for interferon-induced (2'-5')oligo(A) synthetase mRNA from human cells. Proc Natl Acad Sci U S A (1983) 1.73
Selective reduction of c-myc mRNA in Daudi cells by human beta interferon. Proc Natl Acad Sci U S A (1984) 1.65
Activation of a translocated c-myc gene: role of structural alterations in the upstream region. Proc Natl Acad Sci U S A (1984) 1.61
Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon. J Gen Virol (1975) 1.57
Regulation of lymphocyte mitogenesis by (2'--5') oligo-isoadenylate. Nature (1980) 1.35
Biochemical correlates of phenotypic reversion in interferon-treated mouse cells transformed by a human oncogene. Biochem Biophys Res Commun (1984) 1.29
Human fibroblast interferon. An improved purification. J Biol Chem (1981) 1.18
Growth inhibition of human lymphoblastoid Daudi cells in vitro by interferon preparations. Arch Virol (1976) 1.10
Reduced synthesis of pp60src and expression of the transformation-related phenotype in interferon-treated Rous sarcoma virus-transformed rat cells. Mol Cell Biol (1983) 0.96
SV40 RNA: filter hybridization for rapid isolation and characterization of rare RNAs. Anal Biochem (1982) 0.94
Phosphoproteins altered by antiproliferative doses of human interferon- beta in a human bladder carcinoma cell line. Biochem Biophys Res Commun (1984) 0.93
ATP-dependent reduction of azide and HCN by N2-fixing enzymes of Azotobacter vinelandii and Clostridium pasteurianum. Biochim Biophys Acta (1967) 5.81
Transcriptional induction of two genes in human cells by beta interferon. Proc Natl Acad Sci U S A (1984) 4.84
Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61
Characterization of a new low molecular weight RNA in HeLa cell ribosomes. J Mol Biol (1968) 4.44
Reduction of N2O by biological N2-fixing systems. Biochem Biophys Res Commun (1966) 3.66
Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. Antimicrob Agents Chemother (2000) 3.54
Human fibroblast interferon: amino acid analysis and amino terminal amino acid sequence. Science (1980) 2.77
Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A (1996) 2.45
Interferon: purification and initial characterization from human diploid cells. Proc Natl Acad Sci U S A (1976) 2.45
Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence. J Biol Chem (1986) 2.37
Fibroblast interferon induces synthesis of four proteins in human fibroblast cells. Proc Natl Acad Sci U S A (1979) 2.01
Neutrophilia and congestive heart failure after acute myocardial infarction. Am Heart J (2000) 2.01
In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol (1996) 1.98
Cloning and structural analysis of integrated woodchuck hepatitis virus sequences from hepatocellular carcinomas of woodchucks. Cell (1982) 1.91
Mutational analysis of simian virus 40 T antigen: stimulation of cellular DNA synthesis and activation of rRNA genes by mutants with deletions in the T-antigen gene. Mol Cell Biol (1983) 1.81
Distribution of 5 s RNA in HeLa cells. J Mol Biol (1967) 1.78
An energy-dependent hydrogen-evolution from dithionite in nitrogen-fixing extracts of Clostridium pasteurianum. Biochem Biophys Res Commun (1965) 1.77
Interferon-induced proteins. Purification and characterization of a 15,000-dalton protein from human and bovine cells induced by interferon. J Biol Chem (1984) 1.74
Selective reduction of c-myc mRNA in Daudi cells by human beta interferon. Proc Natl Acad Sci U S A (1984) 1.65
Heterogeneity of purified mouse interferons. J Biol Chem (1975) 1.61
Support, mutual aid and recovery from dual diagnosis. Community Ment Health J (2000) 1.61
Characterization and biological activity of cloned simian virus 40 DNA fragments. J Biol Chem (1981) 1.51
A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol (1991) 1.47
A bioluminescent assay for agonist activity at potentially any G-protein-coupled receptor. Anal Biochem (1997) 1.47
Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav (2009) 1.37
Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway. J Neurosci (1998) 1.34
Selection conditions affect the evolution of specific mutations in the reverse transcriptase gene associated with resistance to DMP 266. AIDS (1996) 1.34
Clumsiness in children--do they grow out of it? A 10-year follow-up study. Dev Med Child Neurol (1991) 1.29
Cyclic urea amides: HIV-1 protease inhibitors with low nanomolar potency against both wild type and protease inhibitor resistant mutants of HIV. J Med Chem (1997) 1.27
Recovery challenges among dually diagnosed individuals. J Subst Abuse Treat (2000) 1.24
Isolation and characteristics of flavodoxin from nitrogen-fixing Clostridium pasteurianum. J Biol Chem (1966) 1.23
Messenger RNA editing of the human serotonin 5-HT2C receptor. Neuropsychopharmacology (1999) 1.23
Consumers as peer specialists on intensive case management teams: impact on client outcomes. Psychiatr Serv (1995) 1.22
Human fibroblast interferon. An improved purification. J Biol Chem (1981) 1.18
In vivo and in vitro synthesis of human rhinovirus type 2 ribonucleic acid. J Virol (1972) 1.18
A cell surface alteration in mouse L cells induced by interferon. Biochem Biophys Res Commun (1977) 1.18
Antiviral and cell growth inhibitory activities reside in the same glycoprotein of human fibroblast interferon. Nature (1976) 1.18
Orthopaedic intervention in early rheumatoid arthritis. Occurrence and predictive factors in an inception cohort of 1064 patients followed for 5 years. Rheumatology (Oxford) (2004) 1.16
A 15-kDa interferon-induced protein is derived by COOH-terminal processing of a 17-kDa precursor. J Biol Chem (1988) 1.15
Identification of adenovirus 2 early genes required for induction of cellular DNA synthesis in resting hamster cells. J Virol (1981) 1.11
Proceedings: Aortic valve replacement using fresh unstented homografts. Thoraxchir Vask Chir (1973) 1.11
Nonidentical induction of the guanylate binding protein and the 56K protein by type I and type II interferons. J Interferon Res (1986) 1.09
Flavodoxin: a flavoprotein with ferredoxin activity from Clostrium pasteurianum. Biochim Biophys Acta (1966) 1.08
Identification of an SV40 DNA sequence related to the reactivation of silent rRNA genes in human greater than mouse hybrid cells. Virology (1981) 1.07
De novo purine synthesis in human lymphocytes. Partial co-purification of the enzymes and some properties of the pathway. J Biol Chem (1983) 1.01
Chronic nutmeg psychosis. J R Soc Med (1993) 0.97
Flavodoxin. Chemical and biological properties. J Biol Chem (1967) 0.97
Changes in levels of actin and tubulin mRNAs upon the lectin activation of lymphocytes. Mol Cell Biol (1984) 0.96
One-carbon metabolism in lectin-activated human lymphocytes. Arch Biochem Biophys (1985) 0.95
Orthodeoxia: a new finding in interstitial fibrosis. Am Rev Respir Dis (1987) 0.94
The use of "fresh" unstented homograft valves for replacement of the aortic valve: analysis of 6 1/2 years experience. Circulation (1977) 0.93
Oral anticoagulation in atrial fibrillation: A pan-European patient survey. Eur J Intern Med (2007) 0.93
Construction of infectious molecular clones of HIV-1 containing defined mutations in the protease gene. Biochem Biophys Res Commun (1994) 0.92
Mitochondria-associated ribonucleic acid of the HeLa cell. Effect of ethidium bromide on the synthesis of ribosomal and 4S ribonucleic acid. Biochemistry (1969) 0.91
Coronary angiography Review of 1500 consecutive cases. Br Heart J (1976) 0.90
Fatal hypercalcaemia complicating carcinoma of breast, resistant to cortisone and phosphate administration. Br Med J (1967) 0.88
Interferon-Sepharose: induction of the antiviral state. Biochem Biophys Res Commun (1974) 0.87
Human interferon-beta: effects of deglycosylation. J Interferon Res (1982) 0.87
Genetic content of a 20.9 kb segment of human herpesvirus 6B strain Z29 spanning the homologs of human herpesvirus 6A genes U40-57 and containing the origin of DNA replication. Arch Virol (1997) 0.87
Otogenic pneumocephalus secondary to chronic otitis media. Arch Otolaryngol (1980) 0.86
Preparation of 125iodine-labelled human fibroblast interferon. J Gen Virol (1978) 0.85
Cytoplasmic regulation of two G1-specific temperature-sensitive functions. Cell (1979) 0.84
X-ray studies on phospholipid bilayers. II. Polymorphic forms of dipalmitoyl phosphatidylethanolamine. Z Naturforsch C (1983) 0.84
A 15-kD interferon-induced protein and its 17-kD precursor: expression in Escherichia coli, purification, and characterization. J Interferon Res (1989) 0.83
Comparison of doxorubicin with cycloleucine in the treatment of sarcomas. Cancer Treat Rep (1981) 0.83
Interferon-beta enhances the synthesis of a 20,000-dalton membrane protein: a correlation with the cessation of cell growth. J Interferon Res (1985) 0.83
Managed care: recovery enhancer or inhibitor? Psychiatr Serv (2001) 0.83
Vascular access for cancer chemotherapy. JAMA (1977) 0.83
Comparison of a 20 kb region of human herpesvirus 6B with other human beta herpesviruses reveals conserved replication genes and adjacent divergent open reading frames. Arch Virol (1997) 0.82
The cytoplasmic appearance of three functions expressed during the G0 leds to G1 leads to S transition is nucleus-dependent. J Cell Physiol (1980) 0.81
Cataractogenesis in transgenic mice containing the HIV-1 protease linked to the lens alpha A-crystallin promoter. J Biol Chem (1996) 0.81
Aortic valve replacement using fresh unstented homografts. Br Heart J (1973) 0.81
Impact of gavage dosing procedure and gastric content on adverse respiratory effects and mortality in rat toxicity studies. J Appl Toxicol (2010) 0.81
Microinjected pBR322 stimulates cellular DNA synthesis in Swiss 3T3 cells. Proc Natl Acad Sci U S A (1984) 0.80
Structure and differential mechanisms of regulation of expression of a serine esterase gene in activated human T lymphocytes. J Biol Chem (1988) 0.79
Interferons and the regulation of oncogenes. Interferon (1986) 0.79
Terminal incorporation of 2'-deoxyadenosine into polyadenylate segments of polyadenylated RNA in G1-phase-arrested human T-lymphoblasts. Cancer Res (1983) 0.79
The effects of lectin transformation on cytoplasmic polyadenylated RNA from human lymphocytes. Mol Cell Biochem (1983) 0.78
Transurethral resection of the prostate: still the gold standard. Aust N Z J Surg (1997) 0.78
Proceedings: Coronary angiography using Judkins method. Br Heart J (1974) 0.78
Production and characterization of recombinant mouse brain-derived neurotrophic factor and rat neurotrophin-3 expressed in insect cells. J Neurochem (1994) 0.78
Antibodies to synthetic peptides of human interferon-beta. Use in biosynthetic studies. J Biol Chem (1984) 0.77
Proceedings: Late results of mitral valve replacement using "fresh" unstented aortic homografts. Thoraxchir Vask Chir (1973) 0.77
Interferon: effect on the saturation density to which mouse cells will grow in vitro. J Cell Biol (1973) 0.76
Stimulation of Pyrophosphatase Activity in Clostridium pasteurianum by Reductants. J Bacteriol (1965) 0.75
Turnover of HeLa ribosomal RNA. The characterization of a class of RNA in HeLa cytoplasm derived from 28S RNA. J Cell Biol (1971) 0.75
Transfer RNA: A comparison by gel electrophoresis of the tRNA in HeLa cytoplasm, HeLa mitochondrial fraction, and E. coli. Proc Natl Acad Sci U S A (1969) 0.75
Chemical synthesis and expression of a gene encoding HIV-1 TAT protein. Biochem Biophys Res Commun (1989) 0.75
Comparison of 5-azacytidine (NSC-102816) with CCNU (NSC-79037) in the treatment of patients with breast cancer and evaluation of the subsequent use of cyclophosphamide (NSC-26271). Cancer Chemother Rep (1975) 0.75
Meniere's disease--is surgery really necessary? Laryngoscope (1967) 0.75